Dec 2, 2021 07:00AM
Nov 24, 2021 07:00AM
Oct 13, 2021 07:00AM
Oct 8, 2021 07:00AM
Sep 22, 2021 07:30AM
Sep 20, 2021 07:00AM
Aug 11, 2021 07:00AM Algernon Pharmaceuticals Announces Small Cell Lung Cancer Ifenprodil Research Program and Appoints Dr. William North as Lead Consultant
Aug 9, 2021 07:00AM
Jul 6, 2021 08:30AM
Jun 3, 2021 07:00AM
May 17, 2021 07:00AM
Apr 26, 2021 08:07AM
Apr 26, 2021 08:00AM
Apr 8, 2021 07:00AM Algernon Pharmaceuticals to File End-of-Phase 2 Meeting Request with U.S. FDA for Possible Ifenprodil Phase 3 COVID-19 Trial
Mar 31, 2021 08:00AM
Mar 17, 2021 07:00AM
Feb 19, 2021 08:00AM
Feb 1, 2021 07:30AM
Jan 7, 2021 08:00AM
Dec 30, 2020 08:00AM
Dec 17, 2020 08:00AM Algernon Pharmaceuticals Provides Additional Information on Phase 2b/3 Ifenprodil COVID-19 Study Interim Data
Dec 15, 2020 08:15AM
Jun 25, 2020 08:00AM
Jun 4, 2020 12:10PM
May 26, 2020 08:49AM
May 25, 2020 08:00AM
May 15, 2020 08:30AM
Apr 30, 2020 09:15AM Algernon Receives Clearance from Health Canada for Ifenprodil COVID-19 Phase 2b/3 Multinational Clinical Trial
Apr 29, 2020 03:09PM
Apr 22, 2020 07:30AM
Apr 15, 2020 08:30AM
Apr 13, 2020 08:30AM
Apr 8, 2020 08:30AM
Mar 24, 2020 08:30AM
Mar 13, 2020 02:56PM Algernon Contacts Gates Foundation Regarding Funding for New Coronavirus Treatments
Mar 13, 2020 08:30AM
Nov 25, 2019 07:00AM

327,748 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All